As 23andMe Faces Bankruptcy, Home Testing Shows Warts

By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue

HIGH-STAKES DRAMA SURROUNDING 23ANDME’S BANKRUPTCY—including CEO Anne Wojcicki resigning to try to bid for the company she cofounded and state prosecutors urging caution about the data privacy of the company’s customers—brings up a fundamental question regarding d…

Read More

---

Pathologist Frederick Kiechle, MD, Molecular Pioneer, Dies at 78

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

Clinical pathology lost one of its greatest practitioners when pathologist Frederick L. Kiechle, MD, PhD, FCAP, of Cooper City, Fla., died on July 30, 2024, at the age of 78. …

Read More

---

CMS: TJC Made ‘Business Decision’ to Not Recognize COLA

By Scott Wallask | From the Volume XXX, No. 9 – June 19, 2023 Issue

Following up on a prior briefing, The Dark Report has learned that the Centers for Medicare and Medicaid Services (CMS) does not appear to hav…

Read More

---

Tough Times Ahead for Hospitals and Their Labs

By Robert Michel | From the Volume XXIX, No. 11 – August 8, 2022 Issue

CEO SUMMARY: These are challenging times for the nation’s hospitals, health systems, and clinical labs. A perfect storm involving unprecedented shortages of lab staff, nurses, and other professionals with inflation-fueled cost increases and deteriorating hospital finances was a major topic of…

Read More

---

In Post-COVID-19 Market, IVD Manufacturers Face Supply, Staff Challenges

By Robert Michel | From the Volume XXIX, No. 10 – July 18, 2022 Issue

CEO SUMMARY: After making billions during the COVID-19 pandemic, in vitro diagnostics (IVD) manufacturers must now adjust their strategies and relationships with clinical laboratory customers. Because many contracts for automated instruments are coming due, some IVD companies have t…

Read More

---

‘Lab Workforce Crisis Takes Top Spot’–CAP Today

By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue

CEO SUMMARY: Just weeks ago, CAP Today characterized the current crisis in staffing clinical laboratories as going “from simmer to rolling boil.” Demand for medical technologists and other certified laboratory scientists far exceeds the supply. Consequently, many labs now…

Read More

---

LabCorp, Quest Talk about Medicare Lab Price Cuts

By Robert Michel | From the Volume XXIV No. 11 – August 7, 2017 Issue

CEO SUMMARY: In an effort to forestall CMS’ efforts to implement the PAMA final rule on market price reporting, Laboratory Corporation of America and Quest Diagnostics are meeting with members of Congress, officials in the administration, and the new leadership of CMS. During recent con…

Read More

---

Lean Used to Lay Groundwork for Lab’s 15189 Accreditation

By Joseph Burns | From the Volume XXI No. 2 – February 3, 2014 Issue

CEO SUMMARY: Henry Ford Health System’s laboratory organization has become first in the nation to have all its laboratory sites “standardized under one source of leadership” and accredited to the standards of ISO 15189: Medical Laboratories. The journey to achieve this current state…

Read More

---

All-Star Vitamin D Panel Looks at Lab Challenges

By Robert Michel | From the Volume XVI No. 10 – July 20, 2009 Issue

CEO SUMMARY: Need proof that the issues surrounding today’s Vitamin 25(OH) D are of keen interest to laboratory professionals? Not only did the EXECUTIVE WAR COLLEGE’S in depth sessions on Vitamin D draw a large audience and enthusiastic participation by attendees, but within…

Read More

---

Multi-Modality Diagnosis Heading for Lab Medicine

By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue

CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnost…

Read More

---